A phase I, dose-escalation study of weekly vinflunine in patients with advanced solid tumours
Introduction: We aimed to investigate the dose-limiting toxicity and to determine the maximum tolerated dose of vinflunine (Javlor®, Pierre Fabre, Castres, France) given by weekly intravenous infusions for at least four consecutive weeks in patients with advanced solid tumours and to explore the pharmacokinetic profile...